Now the pharmaceutical investment industry has become a hot topic. If you want to emerge in the industry, you must research and analyze the fatal points in the investment. Expectations are too high, and it may not be a good idea to change the lights. When you identify a strategy, you must stick to a strategy for a long time when you put it into practice. You can't change it or change traders frequently. The marketing strategy suddenly changes, and the competition strategy suddenly changes. Opportunities follow the trend and companies suffer huge losses. The following is an introduction, pharmaceutical companies need to be highly vigilant in doing drug investment.

First of all, the failure of drug investment enterprises to innovate is a dead end. Some companies or individuals have succeeded, always like to take the past ideas to run new varieties. They don't know that any new products are different. The core selling points and expressiveness of their consumption objects and products are different, and empiricism is very easy to make products go. Detours, and even marketing failures. Drug investment has pointed out that as the top level of the company, the CEOs must also go to the market to understand the latest developments and advance with the times in order to understand innovation.

Second, the advertising of pharmaceutical investment enterprises was too perfect and they did not catch the attention of customers. Many advertisers or advertising companies, when doing creative work, create ideas for creativity, pursue aestheticism, and put many profound ideas into the picture of performance, especially TV commercials, just a few tens of seconds, consumers are simply too late. Comprehension passed and confused. I do not know what the company is selling. Obviously, this is a waste of advertising.

Finally, as an old product, packaging must be updated frequently, but it is necessary to follow the original core memory points, so that it is possible to find a way out of innovation and become successful. If your new drug station is not stable in the drug investment market, you must find a good reason, and open up the confusion to make the drug investment companies better investment. Domestic pharmaceutical investment companies are experiencing a “middle-aged puzzle syndrome”: they show collective fallacy, collective panic, and collective restructuring. However, when they calm their minds and contemplate the moon, they will find out whether they are from the law of social development or from Judging from the law of industrial development, the market has entered a new era.